Last update :
19/11/2024
References   References 2774  
Type : Journal
Web link : https://doi.org/10.1345/aph.1D335

Research teams : Westborough - AstraZeneca LP
Authors : McKenzie J.E, Mario Cruz-Rivera M.
Title : Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.
Reference : Ann Pharmacotherapy ; 38: 967-972. 2004

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
aerosolBudesonide Anti-inflammatory
aerosolCromoglycate sodium Various
aerosolIpratropium bromide Antimuscarinic
aerosolLevalbuterol Beta-stimulant
aerosolSalbutamol sulfate Beta-stimulant
Stability of mixtures
Not specified None 
23-26°C Light
aerosol Budesonide liquid Pulmicort® 0.23 mg/ml
aerosol Salbutamol sulfate liquid Proventil® 4.75 mg/ml
0.5 Hour
Not specified None 
23-26°C Light
aerosol Salbutamol sulfate liquid Proventil® 4.83 mg/ml
aerosol Budesonide liquid Pulmicort® 0.48 mg/ml
0.5 Hour
Not specified None 
23-26°C Light
aerosol Budesonide liquid Pulmicort® 0.23 mg/mL
aerosol Cromoglycate sodium liquid Intal® 22 mg/mL
0.5 Hour
Not specified None 
23-26°C Light
aerosol Budesonide liquid Pulmicort® 0.5 mg/mL
aerosol Cromoglycate sodium liquid Intal® 22 mg/mL
0.5 Hour
Not specified None 
23-26°C Light
aerosol Budesonide liquid Pulmicort® 0.23 mg/mL
aerosol Ipratropium bromide liquid Atrovent® 0.20 mg/mL
0.5 Hour
Not specified None 
23-26°C Light
aerosol Budesonide liquid Pulmicort® 0.48mg/mL
aerosol Ipratropium bromide liquid Atrovent® 0.20mg/mL
0.5 Hour
Not specified None 
23-26°C Light
aerosol Levalbuterol liquid Levalbuterol® 0.80mg/mL
aerosol Budesonide liquid Pulmicort® 0.22mg/mL
0.5 Hour
Not specified None 
23-26°C Light
aerosol Budesonide liquid Pulmicort® 0.22mg/mL
aerosol Levalbuterol liquid Levalbuterol® 1.23mg/mL
0.5 Hour
Not specified None 
23-26°C Light
aerosol Budesonide liquid Pulmicort® 0.45mg/mL
aerosol Levalbuterol liquid Levalbuterol® 0.74mg/mL
0.5 Hour

  Mentions Légales